US stock · US markets · public data

VTRS

Viatris Inc · Healthcare

Reference price$17.25Updated according to the public source
P/E—
P/B1.40
ROE-2.75%
Reported DY3.00%
Net margin-2.78%
Net debt/equity0.96
Market capUS$ 19.8 B
Volume (shares)9,240,000
SectorHealthcare
Overview

About VTRS

Indicadores públicos consolidados

Viatris Inc (VTRS) is a stock traded in US markets in the Healthcare sector. The consulted sources did not provide revenue, net income or operating cash flow for the latest reported periods.

No financial statements are available from the consulted sources; missing figures must not be interpreted as zero.

Distributions

Dividends and distributions · last 12 records

public data

The source returned no recent distributions for this asset.

SEC records describe reported fiscal periods, not ex-dividend or payment dates. Only separately reported quarters are shown; missing quarters do not mean zero dividends.

Financials

Income statement, balance sheet and cash flow

No data

Financial statements are not available for this asset yet.

FAQ

Frequently asked questions

What is the price of VTRS?

The reference price available for VTRS is $17.25.

What is the P/B of VTRS?

The P/B of VTRS is 1.40. This compares price with reported book value per share.

What is the ROE of VTRS?

The ROE (Return on Equity) of VTRS is -2.75%. This relates the reported net result to shareholders' equity.

What is the dividend yield of VTRS?

The dividend yield of VTRS is 3.00%. The provider may use annualized dividends; this is not a guaranteed return.

What is the market cap of VTRS?

The market capitalization of VTRS is US$ 19.8 B.

What is the net margin of VTRS?

The net profit margin of VTRS is -2.78%. This relates the reported net result to revenue.

What is the net debt-to-equity ratio of VTRS?

The reported net debt-to-equity ratio of VTRS is 0.96. This compares net debt, after cash, with shareholders' equity.

What sector is VTRS in?

VTRS operates in the Healthcare sector.

FundamentalRadar · educational information, not investment advice.